Loading...
Loading...
Citigroup upgraded
Eli Lilly and CoLLY from Neutral to Buy.
Eli Lilly shares have gained 20.44 percent over the past 52 weeks, while the S&P 500 index has surged 12.25 percent in the same period.
Eli Lilly shares rose 1.64 percent to $72.35 in pre-market trading.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in